Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Arecor Therapeutics PLC ( (GB:AREC) ) has issued an announcement.
Arecor Therapeutics has entered into a collaboration with a major global pharmaceutical company to develop a novel formulation of the partner’s proprietary product using Arecor’s Arestat™ technology. This partnership, which is fully funded by the partner, underscores Arecor’s leadership in drug delivery and formulation innovation, potentially leading to future licensing opportunities and enhancing its market positioning.
More about Arecor Therapeutics PLC
Arecor Therapeutics plc is a biopharmaceutical company focused on transforming patient care by enhancing existing therapeutic products. Utilizing its proprietary technology platform, Arestat™, Arecor develops an internal portfolio of products in diabetes and other areas, and collaborates with leading pharmaceutical and biotechnology companies to deliver innovative therapeutic solutions.
YTD Price Performance: -33.33%
Average Trading Volume: 11,996
Technical Sentiment Signal: Buy
Current Market Cap: £18.5M
See more data about AREC stock on TipRanks’ Stock Analysis page.